Crossmark

HALT & REVERSE: Hsf1 activators lower cardiomyocyt damage; towards a novel approach to REVERSE atrial fibrillation

Crossref DOI link: https://doi.org/10.1186/s12967-015-0714-7

Published Online: 2015-11-05

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lanters, Eva A. H.

van Marion, Denise M. S.

Kik, Charles

Steen, Herman

Bogers, Ad J. J. C.

Allessie, Maurits A.

Brundel, Bianca J. J. M.

de Groot, Natasja M. S.
Funding

Funding for this research was provided by:

Erasmus Medical Center fellowship

Hartstichting (2011T046, 2013T144, 2013T096)

CoolSingel (212)

LSH-Impulse grant (40-43100-98-008)

Bayer

Boehringer Ingelheim

LSH-Impulse grant (40-43100-98-008)